FDAnews
FDAnews Device Daily Bulletin

BOSTON SCI-GUIDANT DEAL FACES EUROPEAN DELAY

March 29, 2006

The European Commission said Monday it has postponed the deadline for completing its antitrust review of Boston Scientific Corp.'s proposed $27 billion acquisition of Guidant Corp. The European Commission's new deadline is April 18. The companies had hoped to finalize the deal during the first week of April. St. Paul Business Journal (http://twincities.bizjournals.com/twincities/stories/2006/03/27/daily3.html)